Triacin

Triacin is a pharmaceutical company primarily known for its commercial-stage respiratory and allergy products. The company focuses on the development and distribution of combination therapies for the treatment of symptoms associated with the common cold, allergic rhinitis, and upper respiratory infections. Its most prominent product line includes Triacin-C, a prescription cough syrup containing a combination of triprolidine, pseudoephedrine, and codeine. Triacin operates within the generic and specialty pharmaceutical markets, providing cost-effective solutions for symptomatic relief in both adult and pediatric populations. The company maintains a focus on traditional small molecule formulations and established therapeutic protocols.